1675248-19-7: Tofacitinib Amide Impurity

Tofacitinib Amide Impurity (CAS No: 1675248-19-7) Or 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide, Tofacitinib Amide is an impurity of Tofacitinib, Tofacitinib is JAK inhibitor, application for the treatment of several diseases, such as inflammatory bowel disease, rheumatoid arthritis, and psoriasis.

Additional information on CAS 1675248-19-7

Catalogue No.

VE008141

CAS No.

1675248-19-7

Molecular Formula

C16H22N6O2

Molecular Weight

330.38 g/mol

Parent drug

Tofacitinib

IUPAC Name

3-((3R, 4R)-4-Methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

Synonyms

N/A

References

Sci-Hub, Metabolic activation of tofacitinib mediated by myeloperoxidase in vitro, 10.1021/acs.chemrestox.9b00280. (2019). Retrieved January 29, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1021/acs.chemrestox.9b00280 ?

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

1675248-19-7: Tofacitinib Amide Impurity

1675248-19-7: Tofacitinib Amide Impurity
Catalogue No.

VE008141

CAS No.

1675248-19-7

Molecular Formula

C16H22N6O2

Molecular Weight

330.38 g/mol

Parent drug

Tofacitinib

IUPAC Name

3-((3R, 4R)-4-Methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

Synonyms

N/A

References

Sci-Hub, Metabolic activation of tofacitinib mediated by myeloperoxidase in vitro, 10.1021/acs.chemrestox.9b00280. (2019). Retrieved January 29, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1021/acs.chemrestox.9b00280 ?

Status

In-stock

ListName

Tofacitinib Amide Impurity

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden